// App-Quantinova.ai

1028 : Effect of miRNA-205 on VEGFA and FGF2 and on resistance to chemotherapeutics in breast cancer.

Researchers

Presenter

  • Yunhui Hu

Principal Investigators

  • Rong Guo

  • Jiayang Wei

  • Jing Zhao

  • Jingjing Liu

  • Jin Zhang

Medical Centers

  • China Tianjin Cancer Prevention Treatment and Research Center, Tianjin Medical University Cancer Hospital, National Clinical Research Center of Cancer, Tianjin, China

  • China Tianjin Cancer Prevention Treatment and Research Center, Tianjin Medical University Cancer Hospital, National Clinical Research Center of Cancer, Tianjin, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Basic fibroblast growth factor

Drug/Treatment

  • Doxorubicin

  • Paclitaxel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved